We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Terason Partners With Aloka for European Market

By HospiMedica staff writers
Posted on 16 Nov 2005
Terason (Burlington, MA, USA; www.terason.com), a leading developer of high-performance laptop ultrasound imaging systems, has signed a distribution agreement for the European market with Aloka Holding Europe AG (Tokyo, Japan; www.aloka.com), a leading manufacturer and distributor of ultrasound systems.

The agreement names Aloka as Terason's exclusive European distributor for the Terason t3000 ultrasound system. "The same attributes that make Terason ultrasound systems popular with a wide range of clinical specialties in the U.S. and Asia--superior image quality, mobility, and connectivity--make our systems ideal for a broad range of European markets as well,” said Alice Chiang, Ph.D., Teratech president and CEO. "Aloka, with decades of successful experience in the European ultrasound market, is a natural distribution choice. This agreement is an important step to increase our momentum in the European market.”

"We are pleased to be associated with the exciting new technology that Terason has developed, and to have been selected to introduce Terason's Windows-based compact, convertible t3000 ultrasound system to the European market,” said Dr. Stephan Suwald, president, Aloka Holding Europe AG. "We look forward to putting this innovative technology into the hands of clinicians throughout Europe.”





Related Links:
Terason
Aloka
Mammography System (Analog)
MAM VENUS
Radiation Safety Barrier
RayShield Intensi-Barrier
Half Apron
Demi
Diagnostic Ultrasound System
DC-80A

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.